Target intelligence / Profile preview

High mobility group box 3 pseudogene 26 (HMGB3P26)

Target: HMGB3P26
Molecular classification: Other

Overview

High mobility group box 3 pseudogene 26 (HMGB3P26) is a pseudogene, meaning it is a DNA segment that closely resembles a known gene but has lost its ability to encode a functional protein product, usually due to mutations or lack of regulatory elements. Pseudogenes like HMGB3P26 may be transcribed at low levels but are typically non-functional and are not considered therapeutic targets, receptors, enzymes, or involved in canonical biological processes or disease mechanisms[1][3].

Other names: HMGB3P26

Beyond the preview

Go deeper on High mobility group box 3 pseudogene 26 (HMGB3P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 3 pseudogene 26 (HMGB3P26).

Explore the full profile